CDNA
Caredx Inc

3,277
Loading...
Loading...
News
all
press releases
Do Options Traders Know Something About CareDx Stock We Don't?
Investors need to pay close attention to CDNA stock based on the movements in the options market lately.
Zacks·15d ago
News Placeholder
More News
News Placeholder
Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings
The headline numbers for CareDx (CDNA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·1mo ago
News Placeholder
CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates
CareDx (CDNA) delivered earnings and revenue surprises of -16.67% and -4.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·2mo ago
News Placeholder
Is IDEXX Laboratories Stock Underperforming the Nasdaq?
Despite IDEXX Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
barchart.com·6mo ago
News Placeholder
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case Overturning Prior $96 Million Verdict
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...
Business Wire·6mo ago
News Placeholder
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Johnson Fistel, LLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of...
Business Wire·7mo ago
News Placeholder
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·7mo ago
News Placeholder
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Business Wire·7mo ago
News Placeholder
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...
Business Wire·7mo ago

Latest CDNA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.